Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/bionanotechnology-ii/descriptif_4020018
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4020018

Bionanotechnology II Global Prospects

Langue : Anglais

Coordonnateur : Reisner David E.

Couverture de l’ouvrage Bionanotechnology II

The impact and importance of nanotechnology continues to grow, and nanomedicine and biotechnology have become areas of increased development. Biomedical engineers who work with biological processes and structures must have a deeply rooted understanding of the role of bionanotechnology, a rapidly evolving sector of the nanotechnology field. Bionanotechnology II: Global Prospects, a follow-up to the editor?s highly successful first volume, contains 26 entirely new contributions that provide a broad survey of research shaping this critical field. With coverage of technical and nontechnical areas, the book offers representative reporting on a wide variety of activity from around the world. It discusses the role of nanotechnology in novel medical devices, bioanalytical technologies, and nanobiomaterials.

Topics discussed include:

  • Emerging microscale technologies
  • Bionanotech-based water treatment
  • Tissue engineering and drug delivery
  • Antimicrobial nanomaterials in the textile industry
  • Bionanotechnology applications in plants and agriculture

With contributions from researchers in Israel, Egypt, Iran, Jordan, Singapore, South Africa, Turkey, Thailand, Argentina, the United Kingdom, and the United States, this volume presents a worldwide perspective on some of the critical areas shaping bionanotechnology today.

SP1 Protein-Gold Nanoparticle Hybrids as Building Blocks for Nanofabrication of One-Dimensional Systems.Bionanotechnology Strategies for Cell Detection. Gold Nanoparticles in Biomedicine. Theragnostic Nanoparticles with the Power to Diagnose, Treat, and Monitor Diseases. Plasmonic Nanostructures in Biosensing. Emerging Microscale Technologies for Global Health: CD4+ Counts. Nanoviricides—A Novel Approach to Antiviral Therapeutics. Antibody-Conjugated Nanoparticles of Biodegradable Polymers for Targeted Drug Delivery. The Biosynthesis of Anisotropic Nanoparticles. Nanotechnology in Biomaterials: Nanofibers in Tissue Engineering. Nanotechnology in Biomaterials: Nanoparticulates as Drug Delivery Systems. Microscale Technologies for Controlling the Cellular Microenvironment in Time and Space.Think Big, Then Shrink: Low-Cost, Ultra-Rapid Tunable Nanowrinkles from Shape Memory Polymers. Electric Fields for Vaccine Delivery: How In Vivo Electroporation Could Fulfill the Promise of DNA Vaccines. Atomic Force Microscopy as a Nanotool to Investigate Malaria-Infected Erythrocytes. Neural Prosthesis Facilitated by Nanotechnology. Production of Bare Multiple-Element Magnetic Nanoparticles and Their Use in Fast Detection and Removal of Pathogenic Bacteria from Water Resources. Antimicrobial Nanomaterials in the Textile Industry. Recent Advances in Water Desalination Driven by Biotechnology and Nanotechnology. Liposomal pH-Sensitive Nanomedicines in Preclinical Development. Bio- and Nanotechnology Offer High Performance for Water Cleanup. Nanoscience and Engineering for Robust Biosolar Cells. Electrospinning in Drug Delivery. Noble Metal Nanoparticles in Drug Delivery. Photonic Structures in Nature. Bionanotechnology Applications in Plants and Agriculture. Index.

Academic and Professional Practice & Development

David E. Reisner is a well-known early pioneer and entrepreneur in the burgeoning field of nanotechnology. In 1996, he cofounded two nanotech companies in Connecticut: Inframat and U.S. Nanocorp. For nearly 15 years, he was CEO of both companies since founding. He was featured in Forbes in 2004 and was a Technology Pioneer at the World Economic Forum Annual Meeting in Davos. He has over 175 publications and is an inventor on 10 issued patents.